Trademark: 77178675
Word
ACCRETAMAB
Status
Registered
Status Code
800
Status Date
Wednesday, April 10, 2019
Serial Number
77178675
Registration Number
3653037
Registration Date
Tuesday, July 14, 2009
Mark Type
4000
Filing Date
Friday, May 11, 2007
Published for Opposition
Tuesday, April 28, 2009

Trademark Owner History

Classifications
5 [Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases]
40 Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals technical consultation in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals
42 Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells

Trademark Events
Sep 4, 2019
Automatic Update Of Assignment Of Ownership
Apr 10, 2019
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Apr 10, 2019
Registered And Renewed (First Renewal - 10 Yrs)
Apr 10, 2019
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Apr 8, 2019
Teas Section 8 & 9 Received
Jul 14, 2018
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Aug 5, 2015
Notice Of Acceptance Of Sec. 8 - E-Mailed
Aug 5, 2015
Registered - Partial Sec. 8 (6-Yr) Accepted
Aug 5, 2015
Case Assigned To Post Registration Paralegal
Jul 1, 2015
Teas Section 8 Received
Jul 14, 2009
Registered-Principal Register
Apr 28, 2009
Published For Opposition
Apr 8, 2009
Notice Of Publication
Mar 23, 2009
Law Office Publication Review Completed
Mar 23, 2009
Approved For Pub - Principal Register
Feb 24, 2009
Amendment From Applicant Entered
Feb 24, 2009
Correspondence Received In Law Office
Feb 23, 2009
Paper Received
Feb 10, 2009
Inquiry As To Suspension Mailed
Feb 9, 2009
Suspension Inquiry Written
Feb 9, 2009
Amendment From Applicant Entered
Feb 9, 2009
Correspondence Received In Law Office
Feb 6, 2009
Paper Received
Jan 12, 2009
Inquiry As To Suspension Mailed
Jan 11, 2009
Suspension Inquiry Written
Dec 11, 2008
Lie Checked Susp - To Atty For Action
Nov 19, 2008
Automatic Update Of Assignment Of Ownership
Jun 11, 2008
Letter Of Suspension Mailed
Jun 11, 2008
Suspension Letter Written
Jun 10, 2008
Amendment From Applicant Entered
Jun 10, 2008
Correspondence Received In Law Office
Jun 9, 2008
Paper Received
Mar 26, 2008
Inquiry As To Suspension Mailed
Mar 25, 2008
Suspension Inquiry Written
Feb 24, 2008
Lie Checked Susp - To Atty For Action
Feb 24, 2008
Assigned To Lie
Aug 24, 2007
Letter Of Suspension Mailed
Aug 24, 2007
Suspension Letter Written
Aug 24, 2007
Assigned To Examiner
May 16, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24